Abbott Laboratories (ABT) Interest & Investment Income (2009 - 2026)

Abbott Laboratories has disclosed Interest & Investment Income across 18 years of filings, most recently posting $52.0 million for Q2 2026.

• In Q2 2026, Interest & Investment Income fell 26.76% year-over-year to $52.0 million; the TTM figure through Jun 2026 stood at $313.0 million (down 6.57% YoY), while the FY2025 annual figure was $308.0 million, down 49.59% from the prior year.
• Interest & Investment Income came in at $52.0 million for Q2 2026 at Abbott Laboratories, down from $106.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $106.0 million in Q1 2026 to a low of $14.0 million in Q1 2022.
• Average Interest & Investment Income over 5 years is $76.6 million, with a median of $82.0 million recorded in 2024.
• Year-over-year, Interest & Investment Income surged 700.0% in 2022 and fell 26.76% in 2026.
• Over 5 years, Interest & Investment Income stood at $88.0 million in 2022, then rose by 1.14% to $89.0 million in 2023, then advanced by 2.25% to $91.0 million in 2024, then fell by 14.29% to $78.0 million in 2025, then slumped by 33.33% to $52.0 million in 2026.
• Per Business Quant data, the three most recent Interest & Investment Income figures were $52.0 million in Q2 2026, $106.0 million in Q1 2026, and $78.0 million in Q4 2025.